Page 54 - Pharma

Take Solutions launches academy for life sciences industry

Academy aims to create skilled, competent and job-ready workforce for the life sciences industry

Right raw material must for quality alternative medicines: Shripad Naik

According to the minister, review meetings with all stakeholders must be held to understand the bottlenecks they face in taking up large cultivation of medical plants

Apollo Hospitals-backed firm Sapien forms alliance with OncoStem

Two companies tie up for breast cancer recurrence diagnostic test, which is planned to be launched first within the Apollo network in India, followed by a worldwide launch

Lupin launches respiratory device InspiraChamber in US

Launched under a strategic licensing agreement with the US-based company InspiRX Inc, InspiraChamber VHC strengthens Lupin existing brand portfolio in the US

Granules India, Belgian firm Ajinomoto OmniChem open APIs facility

The Visakhapatnam facility will manufacture high-value active pharmaceutical ingredients (APIs) and intermediates

Lupin joins hand with Polish firm Celon for dry powder inhaler product

Both companies will co-develop fluticasone/salmeterol dry powder inhaler product - a generic version of GlaxoSmithKline's Advair Diskus, which had global sales of over $ 7 bn last fiscal

Zydus Cadila completes single rising dose phase I studies for anaemia drug

ZYAN1 is an orally bioavailable hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor, designed to increase the natural production of erythropoietin (EPO)

Aurobindo Pharma expects 25 products approvals in FY16 for US market

Approvals expect to drive 50 per cent growth in its injectables business in the next financial year

Suven Life bags patents for CNS drug in Australia, Canada, Japan, New Zealand

The granted claims of the patent - which is valid until 2030 - include the class of selective H3 ligands discovered by Suven and are being developed as therapeutic agents

Natco files marketing exclusivity application for cancer drug sorafenib

Sorafenib tablet, which is the generic version of Nexavar (marketed by Bayer and Onyx Pharmaceuticals, had recorded sales of approximately $48 mn in the US in 2014

Indian Chemical Council invites nominations for ICC Awards

The last date for submitting the nominations is May 15, 2015

Cipla wins Rs 1170 cr tender to supply HIV drugs from Global Fund

The contract is effective from January 1, 2015 and will run for a period of three years

Cipla to form JV with Biopharm SPA for respiratory products in Algeria

Cipla will own 40% in the JV and will invest $6 million initially

Cipla acquires respiratory device maker Jay Precision for Rs 96 cr

The company has acquired 60% stake in Jay Precision - a move that would serve as platform for developing next generation respiratory devices for Cipla

Natco files ANDA applications for cancer and multiple sclerosis drugs in US

It has applied for Para IV approvals with USFDA for fingolimod (used to treat multiple sclerosis) and cabazitaxel (used for treating patients with hormone-refractory prostate cancer)

Venus Remedies receives patent for antibiotic Vancoplus

Patent, granted by Indian Patent Office, is valid till 2025

Cipla forms a JV in Morocco with Cooper Pharma and PHI

The initial focus of the JV, in which Cipla will invest $ 15 mn, will be respiratory and neurology products and it will also invest in setting up a manufacturing facility in Morocco

Pfizer to acquire Hospira for $17 billion

Acquisition will expand Pfizer's portfolio of sterile injectable and biosimilars, making it one of the global leaders in sterile injectables segment

Minister urges scientists to explore alternative medicines for cancer cure

Shripad Naik, Minister of State for AYUSH, said that a scientific method is required to explore the value from the vast knowledge base of AYUSH for healthcare of cancer patients

Aurobindo Pharma & Tergene Biotech to form JV for vaccines

Aurobindo will hold a majority stake in the JV, which will focus on pneumococcal conjugate vaccine